Komal Priya is an experienced researcher currently employed at Market Access Transformation, a Genesis Research company, since June 2022. Previous roles include Clinical Pharmacist at Bhagwan Mahavir Medica Superspeciality Hospital, where responsibilities involved conducting audits, documenting adverse drug reactions, training nursing staff on drug safety, and optimizing patient medication for health outcomes from March 2017 to January 2020. Prior to this, Komal served as an Inpatient Pharmacist at the same hospital, managing medication dispensing and pharmacy inventory from August 2014 to June 2015 and began a career as an Assistant Operations Officer at Akums Drugs & Pharmaceuticals Ltd from February 2014 to July 2014. Komal is currently pursuing a Master of Public Health at the Indian Institutes of Public Health, having previously earned a Bachelor of Pharmacy from Siksha 'O' Anusandhan University.
This person is not in any offices
Market Access Transformation, a Genesis Research company
**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers